Viomi Technology’s Massive Turnaround: Is This Small-Cap the Next Big Thing?
Gigacloud’s $18 Million Bet: Can The New Classic Deal Supercharge Its Global Marketplace?
Gigacloud Technology’s acquisition of New Classic Home Furnishing boosts its sourcing network and U.S. reach, signaling strategic growth and supply-chain diversification amid global trade volatility.
Beyond Meat’s Collapse Below $1: A Cautionary Tale of Debt, Dilution & Diminishing Demand!
Nektar Therapeutics Gains New Life On Buyout Rumors & Atopic Dermatitis Breakthrough
Business & Market Movers
Stock Market Today: Stocks Surge to Record Highs on Trade Deal Momentum and Fed Rate-Cut Bets
·Oct 27, 2025Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Nektar Therapeutics Gains New Life On Buyout Rumors & Atopic Dermatitis Breakthrough
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast Track status and solid cash reserves, investor optimism builds.
Harrow’s MELT Acquisition Could Disrupt IV Sedation—But Is It The Hottest Pharma Small-Cap Buy?
Zepp Health’s Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
Viomi Technology’s Massive Turnaround: Is This Small-Cap the Next Big Thing?
Viomi Technology’s $20M share buyback through 2027 signals confidence post major restructuring and renewed focus on home water systems, sparking investor optimism despite lingering small-cap risks.
OpenAI and Broadcom Strike Multibillion-Dollar Deal to Build 10 Gigawatts of Custom AI Chips
